Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · Real-Time Price · USD
1.300
-0.170 (-11.56%)
At close: Jan 30, 2026, 4:00 PM EST
1.320
+0.020 (1.52%)
After-hours: Jan 30, 2026, 7:54 PM EST
Bionano Genomics Employees
As of December 31, 2024, Bionano Genomics had 100 total employees, including 98 full-time and 2 part-time employees. The number of employees decreased by 244 or -70.93% compared to the previous year.
Employees
100
Change (1Y)
-244
Growth (1Y)
-70.93%
Revenue / Employee
$287,200
Profits / Employee
-$385,870
Market Cap
13.23M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 100 | -244 | -70.93% | 98 | 2 |
| Dec 31, 2023 | 344 | -61 | -15.06% | 344 | 0 |
| Sep 30, 2023 | 388 | -17 | -4.20% | 388 | 0 |
| Dec 31, 2022 | 405 | 106 | 35.45% | 405 | 0 |
| Dec 31, 2021 | 299 | 152 | 103.40% | 299 | 0 |
| Dec 31, 2020 | 147 | 50 | 51.55% | 147 | 0 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Harvard Bioscience | 355 |
| Jin Medical International | 269 |
| Retractable Technologies | 227 |
| Precision Optics Corporation | 90 |
| Femasys | 71 |
| Ekso Bionics Holdings | 66 |
| Nephros | 31 |
| NEXGEL | 19 |
BNGO News
- 2 months ago - Final 2026 Clinical Lab Fee Schedule Indicates a 47% Increase in Payment Determination for the Category I CPT Code for OGM use in Hematologic Malignancies - GlobeNewsWire
- 2 months ago - Bionano Genomics, Inc. (BNGO) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Bionano Reports Third Quarter 2025 Results and Highlights Recent Business Progress - GlobeNewsWire
- 3 months ago - Bionano Announces Publication Showing OGM Can Overcome Key Limitations of Targeted RNA-Seq for Cytogenetic Investigation in Acute Leukemia - GlobeNewsWire
- 3 months ago - Bionano to Report Third Quarter 2025 Financial Results and Host a Conference Call Webcast on November 13, 2025 - GlobeNewsWire
- 4 months ago - Bionano to Participate in the H.C. Wainwright @ Home Event - GlobeNewsWire
- 4 months ago - Nasdaq Surges 100 Points; Bionano Genomics Shares Plunge - Benzinga
- 4 months ago - Bionano Genomics, Inc. Announces Closing of $10 Million Public Offering - GlobeNewsWire